Telegraph Hill Partners is a venture capital and growth equity firm dedicated to helping life science, medical device, and healthcare companies achieve their growth objectives. Founded in 2001 and based in San Francisco, the firm invests in commercial-stage companies across life science tools, medical technology, healthcare IT, and healthcare services.
31% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $15.4M (across 29 rounds with reported amounts).
Portfolio
28
Fund Size
$525M
Top Stage
Unknown
Last 12 Mo
1
Team
J. Matthew Mackowski
Chairman, Managing Director
Alexander Herzick
Partner
Hart, J.D., CFA
Partner
Robert Shepler
Partner Emeritus
Dinesh Moorjani
Managing Director
Mark Bradt
Managing Director
Matthew Mackowski
Chairman, Managing Director
Alex Herzick
Partner
Paul Grossman
Partner
Andrew Alas
Investment Banking Associate
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Kytopen | Series B | — | Apr 2026 |
 Streamforge | Seed | $1.2M | Jul 2025 |
 Bucketlist | Unknown | $1.2M | Jan 2025 |
 Artemis, Inc. | Pre-Seed | $1.5M | May 2024 |
| AApartool | Series A | — | Oct 2023 |
 UnDosTres | Series B | $30M | Jul 2022 |
 Voila | Series A | $6M | Jan 2022 |
 Rarecyte | Series B | $24M | Sep 2021 |
| NNivagen Pharmaceuticals | Growth | $16M | May 2020 |
 Stamped Technologies | Pre-Seed | $2M | Feb 2020 |
 Nimble Therapeutics | Series A | $10M | Apr 2019 |
 Akoya Biosciences | Unknown | $50M | Jan 2019 |
| AAkoya | Unknown | $50M | Jan 2019 |
 Chewse | Series B | $19M | Dec 2018 |
 Captio | Unknown | $1.1M | Sep 2016 |
 Captio | Unknown | $1.1M | Sep 2016 |
 Fleet | Seed | $4M | Apr 2016 |
| PPneumRx | Series C | — | Jan 2011 |
 Asuragen | Series B | $18.5M | Dec 2007 |
 Vessel | Seed | $7.5M | — |
| PPneumRx | Series B | $27M | — |
 QuoteMachine | Seed | $3.7M | — |
| PProvect.AI | Unknown | $7M | — |
 Mosaic Biosciences | Unknown | $11.4M | — |
| PPrecision NanoSystems | Series A | $6M | — |
Top Co-Investors
Last updated: 27 September 2026